Interferon in relapsing‐remitting multiple sclerosis
45 results
1 - 45
Interferon in relapsing‐remitting multiple sclerosis- Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis
- alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
- Mycophenolate mofetil for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Daclizumab for relapsing remitting multiple sclerosis
- Alemtuzumab for multiple sclerosis
- Fingolimod for relapsing‐remitting multiple sclerosis
- Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta‐analysis
- Azathioprine for people with multiple sclerosis
- Ocrelizumab for multiple sclerosis
- Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
- Interferon Beta for Primary Progressive Multiple Sclerosis
- Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
- Interferon beta for secondary progressive multiple sclerosis
- Statins for multiple sclerosis: Cochrane systematic review
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Natalizumab for relapsing remitting multiple sclerosis
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta‐analysis
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Teriflunomide for multiple sclerosis
- Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis
- Natalizumab for multiple sclerosis